BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
Titel:
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
Auteur:
Zabriskie, Matthew S. Eide, Christopher A. Tantravahi, Srinivas K. Vellore, Nadeem A. Estrada, Johanna Nicolini, Franck E. Khoury, Hanna J. Larson, Richard A. Konopleva, Marina Cortes, Jorge E. Kantarjian, Hagop Jabbour, Elias J. Kornblau, Steven M. Lipton, Jeffrey H. Rea, Delphine Stenke, Leif Barbany, Gisela Lange, Thoralf Hernández-Boluda, Juan-Carlos Ossenkoppele, Gert J. Press, Richard D. Chuah, Charles Goldberg, Stuart L. Wetzler, Meir Mahon, Francois-Xavier Etienne, Gabriel Baccarani, Michele Soverini, Simona Rosti, Gianantonio Rousselot, Philippe Friedman, Ran Deininger, Marie Reynolds, Kimberly R. Heaton, William L. Eiring, Anna M. Pomicter, Anthony D. Khorashad, Jamshid S. Kelley, Todd W. Baron, Riccardo Druker, Brian J. Deininger, Michael W. O’Hare, Thomas